OnKure Therapeutics (OKUR) Institutional Ownership $2.50 +0.01 (+0.40%) Closing price 04:00 PM EasternExtended Trading$2.50 0.00 (-0.20%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for OnKure Therapeutics (NASDAQ:OKUR)CurrentInstitutional OwnershipPercentage90.98%Number ofInstitutional Buyers(last 12 months)31TotalInstitutional Inflows(last 12 months)$63.98MNumber ofInstitutional Sellers(last 12 months)0 Get OKUR Insider Trade Alerts Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OKUR Institutional Buying and Selling by Quarter OnKure Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Vestal Point Capital LP635,000$5.46M0.3%N/A19.012% 2/17/2025Two Sigma Advisers LP14,228$122K0.0%N/A0.426% 2/17/2025Tang Capital Management LLC294,626$2.53M0.2%N/A8.821% 2/17/2025Shay Capital LLC15,016$129K0.0%N/A0.450% 2/17/2025Sphera Funds Management LTD.87,354$751K0.1%N/A2.615% 2/17/2025Prosight Management LP63,754$548K0.2%N/A1.909% 2/17/2025OMERS ADMINISTRATION Corp12,100$104K0.0%N/A0.362% 2/17/2025NEA Management Company LLC478,548$4.12M0.2%N/A14.328% 2/17/2025Millennium Management LLC144,099$1.24M0.0%N/A4.314% 2/17/2025Deep Track Capital LP523,989$4.51M0.2%N/A15.688% Get the Latest News and Ratings for OKUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OnKure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Cubist Systematic Strategies LLC20,549$177K0.0%N/A0.615% 2/17/2025Cantor Fitzgerald L. P.35,700$294K0.0%N/A1.069% 2/17/2025Citadel Advisors LLC1,074,314$8.78M0.0%N/A32.165% 2/17/2025Bank of America Corp DE249,642$2.15M0.0%N/A7.474% 2/17/2025683 Capital Management LLC43,371$373K0.0%N/A1.299% 2/17/2025Acorn Capital Advisors LLC1,439,674$12.38M6.8%N/A43.104% 2/14/2025Samsara BioCapital LLC824,155$7.09M1.0%N/A24.675% 2/14/2025Nantahala Capital Management LLC54,777$471K0.0%N/A1.640% 2/14/2025Northern Trust Corp19,177$165K0.0%N/A0.574% 2/14/2025Boothbay Fund Management LLC78,021$671K0.0%N/A2.336% 2/14/2025Altium Capital Management LLC218,386$1.88M0.5%N/A6.539% 2/13/2025Affinity Asset Advisors LLC144,159$1.24M0.2%N/A4.316% 2/13/2025Carlyle Group Inc.269,895$2.33M0.5%N/A8.081% 2/13/2025Walleye Capital LLC13,495$116K0.0%N/A0.404% 2/13/2025XTX Topco Ltd18,633$160K0.0%N/A0.558% 2/13/2025Barclays PLC8,741$75K0.0%N/A0.262% 2/13/2025Renaissance Technologies LLC47,450$408K0.0%N/A1.421% 2/12/2025Aldebaran Capital LLC45,572$392K0.4%N/A1.363% 2/12/2025Aisling Capital Management LP88,607$762K0.3%N/A2.651% 2/12/2025Geode Capital Management LLC76,599$659K0.0%N/A2.291% 2/12/2025Highbridge Capital Management LLC399,743$3.44M0.1%N/A11.958% (Data available from 1/1/2016 forward) OKUR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OKUR shares? During the previous two years, 31 institutional investors and hedge funds held shares of OnKure Therapeutics. The most heavily invested institutionals were Acorn Capital Advisors LLC ($12.38M), Citadel Advisors LLC ($8.78M), Samsara BioCapital LLC ($7.09M), Vestal Point Capital LP ($5.46M), Deep Track Capital LP ($4.51M), NEA Management Company LLC ($4.12M), and Highbridge Capital Management LLC ($3.44M).Learn more on OKUR's institutional investors. What percentage of OnKure Therapeutics stock is owned by institutional investors? 90.98% of OnKure Therapeutics stock is owned by institutional investors. Learn more on OKUR's institutional investor holdings. Which institutional investors have been buying OnKure Therapeutics stock? Of the 31 institutional investors that purchased OnKure Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acorn Capital Advisors LLC ($1.44M), Citadel Advisors LLC ($1.07M), Samsara BioCapital LLC ($824.16K), Vestal Point Capital LP ($635K), Deep Track Capital LP ($523.99K), NEA Management Company LLC ($478.55K), and Highbridge Capital Management LLC ($399.74K). How much institutional buying is happening at OnKure Therapeutics? Institutional investors have bought a total of 7,439,374 shares in the last 24 months. This purchase volume represents approximately $63.98M in transactions. Related Companies Journey Medical Major Shareholders Fate Therapeutics Major Shareholders 4D Molecular Therapeutics Major Shareholders Puma Biotechnology Major Shareholders Protara Therapeutics Major Shareholders Inhibikase Therapeutics Major Shareholders ProQR Therapeutics Major Shareholders Tiziana Life Sciences Major Shareholders Nkarta Major Shareholders Coherus BioSciences Major Shareholders This page (NASDAQ:OKUR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OKUR Stock Free OKUR Stock Alerts